2001
Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies
Ikeda D, Hylton N, Kinkel K, Hochman M, Kuhl C, Kaiser W, Weinreb J, Smazal S, Degani H, Viehweg P, Barclay J, Schnall M. Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies. Journal Of Magnetic Resonance Imaging 2001, 13: 889-895. PMID: 11382949, DOI: 10.1002/jmri.1127.Peer-Reviewed Original ResearchMeSH KeywordsBreastBreast NeoplasmsContrast MediaDocumentationFemaleHumansImage EnhancementMedical Records Systems, ComputerizedTerminology as TopicConceptsLesion typeUnweighted kappa statisticClinical historyInternal enhancement characteristicsBreast densityBreast MRIBreast magnetic resonance imaging (MRI) examinationsInterobserver agreementMagnetic resonance imaging examinationsMagnetic resonance imaging studyKappa statisticsRadiology Breast ImagingResonance imaging studyModerate interobserver agreementEnhancement characteristicsBreast MRI studiesMass lesionRim enhancementImaging examinationsAmerican CollegeMRI reportingMRI studiesMRI experienceImaging studiesLike enhancementVolumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy.
Lee V, Rofsky N, Morgan G, Teperman L, Krinsky G, Berman P, Weinreb J. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. American Journal Of Roentgenology 2001, 176: 906-8. PMID: 11264075, DOI: 10.2214/ajr.176.4.1760906.Peer-Reviewed Original Research
2000
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Schmiedl U, Brown J, Borrello J, Lee J, Semelka R, Mattrey R, Dachman A, Saini S, Harms S, Mitchell D, Anderson M, Halford H, Bennett W, Young S, Rifkin M, Gay S, Ballerini R, Sherwin P, Robison R. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. Journal Of Magnetic Resonance Imaging 2000, 12: 689-701. PMID: 11050638, DOI: 10.1002/1522-2586(200011)12:5<689::aid-jmri5>3.0.co;2-z.Peer-Reviewed Original ResearchConceptsUnenhanced magnetic resonance imagingMagnetic resonance imagingMangafodipir trisodium injectionFinal diagnosisMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsContrast-enhanced magnetic resonance imagingInjection of MnDPDPPatient's final diagnosisHepatic magnetic resonance imagingComputed tomography examinationEnhanced magnetic resonance imagingFocal liver diseaseAdditional diagnostic informationFocal liver lesionsLiver diseaseEarly imagingMRI evaluationHepatic massClinical trialsTomography examinationIntravenous administrationPatient managementRadiologic diagnosisSafety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety)
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Semelka R, Brown J, Borrello J, Lee J, Mattrey R, Dachman A, Saini S, Harmon B, Fenstermacher M, Pelsang R, Harms S, Mitchell D, Halford H, Anderson M, Johnson C, Francis I, Bova J, Kenney P, Klippenstein D, Foster G, Turner D, Stillman A, Nelson R, Young S, Patt R, Rifkin M, Seltzer S, Gay S, Robison R, Sherwin P, Ballerini R. Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety). Journal Of Magnetic Resonance Imaging 2000, 12: 186-197. PMID: 10931579, DOI: 10.1002/1522-2586(200007)12:1<186::aid-jmri21>3.0.co;2-2.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal PainAdultAgedAged, 80 and overCardiovascular DiseasesContrast MediaDiagnosis, DifferentialEdetic AcidFemaleHumansImage EnhancementInjections, IntravenousLiver CirrhosisLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedPainPregnancyPyridoxal PhosphateRisk AssessmentSensitivity and SpecificityVomitingConceptsMagnetic resonance imagingMangafodipir trisodium injectionAdverse eventsMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsUnenhanced magnetic resonance imagingInjection of MnDPDPInjection-associated discomfortSerious adverse eventsShort-term safetyHepatic magnetic resonance imagingComputed tomography examinationSignificant short-term riskShort-term riskFocal liver lesionsClinical trialsTomography examinationLaboratory valuesLiver lesionsResonance imagingVital signsPatientsMnDPDPInjectionHepatic MR Imaging with a Dynamic Contrast-enhanced Isotropic Volumetric Interpolated Breath-hold Examination: Feasibility, Reproducibility, and Technical Quality
Lee V, Lavelle M, Rofsky N, Laub G, Thomasson D, Krinsky G, Weinreb J. Hepatic MR Imaging with a Dynamic Contrast-enhanced Isotropic Volumetric Interpolated Breath-hold Examination: Feasibility, Reproducibility, and Technical Quality. Radiology 2000, 215: 365-72. PMID: 10796909, DOI: 10.1148/radiology.215.2.r00ma16365.Peer-Reviewed Original ResearchMeSH KeywordsAdipose TissueAdultAgedAged, 80 and overCohort StudiesContrast MediaFeasibility StudiesFemaleFollow-Up StudiesGadolinium DTPAHepatic ArteryHepatic VeinsHumansImage EnhancementImage Processing, Computer-AssistedLiverLiver DiseasesMagnetic Resonance ImagingMaleMiddle AgedPortal VeinQuality ControlReproducibility of ResultsRespirationVena Cava, InferiorConceptsContrast materialMagnetic resonance imaging examinationsPatient underwent repeatVascular anatomic variantsDynamic contrastPortal venous phaseArterial dominanceUnderwent repeatVenous anatomyAnatomic variantsImaging examinationsTest bolusTest doseVenous phaseArterial phaseRepeat studyHepatic MRGadopentetate dimeglumineGradient-echo imagingTechnical qualityEnhanced acquisitionMaximal enhancementBreath-hold imagesOriginal study
1999
Abdominal MR Imaging with a Volumetric Interpolated Breath-hold Examination1
Rofsky N, Lee V, Laub G, Pollack M, Krinsky G, Thomasson D, Ambrosino M, Weinreb J. Abdominal MR Imaging with a Volumetric Interpolated Breath-hold Examination1. Radiology 1999, 212: 876-84. PMID: 10478260, DOI: 10.1148/radiology.212.3.r99se34876.Peer-Reviewed Original ResearchA multisite phase III study of the safety and efficacy of a new manganese chloride‐based gastrointestinal contrast agent for MRI of the abdomen and pelvis
Small W, DeSimone‐Macchi D, Parker J, Sukerkar A, Hahn P, Rubin D, Zelch J, Kuhlman J, Outwater E, Weinreb J, Brown J, de Lange E, Woodward P, Arildsen R, Foster G, Runge V, Aisen A, Muroff L, Thoeni R, Parisky Y, Tanenbaum L, Totterman S, Herfkens R, Knudsen J, Laster R, Duerinckx A, Stillman A, Spritzer C, Saini S, Rofsky N, Bernardino M. A multisite phase III study of the safety and efficacy of a new manganese chloride‐based gastrointestinal contrast agent for MRI of the abdomen and pelvis. Journal Of Magnetic Resonance Imaging 1999, 10: 15-24. PMID: 10398973, DOI: 10.1002/(sici)1522-2586(199907)10:1<15::aid-jmri3>3.0.co;2-x.Peer-Reviewed Original ResearchConceptsGastrointestinal contrast agentAdverse eventsSite investigatorsGastrointestinal tract side effectsPatient diagnosisBlinded readersMore adverse eventsPhase III studyInflammatory bowel diseaseGroup of patientsPeptic ulcer diseaseML of placeboT2-weighted MRI scansMultisite clinical trialContrast agentsOral contrast agentAdditional diagnostic informationPlacebo patientsOral agentsIII studyBowel diseaseUlcer diseaseGastrointestinal pathologyLaboratory changesPhysical examination
1996
Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector.
Earls J, Rofsky N, DeCorato D, Krinsky G, Weinreb J. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996, 201: 705-10. PMID: 8939219, DOI: 10.1148/radiology.201.3.8939219.Peer-Reviewed Original ResearchNonspecificity of short inversion time inversion recovery (STIR) as a technique of fat suppression: pitfalls in image interpretation.
Krinsky G, Rofsky N, Weinreb J. Nonspecificity of short inversion time inversion recovery (STIR) as a technique of fat suppression: pitfalls in image interpretation. American Journal Of Roentgenology 1996, 166: 523-6. PMID: 8623620, DOI: 10.2214/ajr.166.3.8623620.Peer-Reviewed Original ResearchMR-guided fine needle aspiration of breast lesions: initial experience.
Wald D, Weinreb J, Newstead G, Flyer M, Bose S. MR-guided fine needle aspiration of breast lesions: initial experience. Journal Of Computer Assisted Tomography 1996, 20: 1-8. PMID: 8576457, DOI: 10.1097/00004728-199601000-00002.Peer-Reviewed Original ResearchConceptsFine-needle aspiration
1995
MR imaging of the breast.
Weinreb J, Newstead G. MR imaging of the breast. Radiology 1995, 196: 593-610. PMID: 7644617, DOI: 10.1148/radiology.196.3.7644617.Peer-Reviewed Original ResearchConceptsBreast MR imagingMR imagingMR imaging-guided biopsyPossible clinical roleImaging-guided biopsyContrast-enhanced MR imagingContrast material-enhanced imagingMagnetic resonance imagingCancer screeningBreast diseaseBreast cancerClinical roleClinical practiceBreast implantsResonance imagingRoutine useBreast massesTreatment planningBiopsyBreastImagingImaging techniquesCancerVariety of rolesDisease
1994
Safety and optimum concentration of a manganese chloride–based oral MR contrast agent
Bernardino M, Weinreb J, Mitchell D, Small W, Morris M. Safety and optimum concentration of a manganese chloride–based oral MR contrast agent. Journal Of Magnetic Resonance Imaging 1994, 4: 872-876. PMID: 7865949, DOI: 10.1002/jmri.1880040620.Peer-Reviewed Original ResearchComparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions initial findings
Birnbaum B, Weinreb J, Fernandez M, Brown J, Rofsky N, Young S. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions initial findings. Clinical Imaging 1994, 18: 21-27. PMID: 8180855, DOI: 10.1016/0899-7071(94)90141-4.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingMn-DPDPMore lesionsRetrospective multi-institutional studyExtensive metastatic diseaseHepatic magnetic resonance imagingMulti-institutional studyFocal hepatic diseaseFocal liver lesionsN'-dipyridoxylethylenediamineMetastatic diseaseIntravenous bolusDose groupFatty liverHepatic diseaseComparison of ContrastHepatic lesionsComputed tomographyLiver lesionsCT studiesPatientsMumol/Resonance imagingBolus contrastLesions